About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Canada

CA038

Back

Regulations Repealing the Manufacturing and Storage of Patented Medicines Regulations, adopted 28 September 2000

 Regulations Repealing the Manufacturing and Storage of Patented Medicines Regulations, adopted 28 September 2000

2000-10-11 Canada Gazette Part lL Vol. 134, No. 21 Gazette du Canada Partie IL Vol. 134, no 21 SORJDORS/2000-373

Registration SOR/2000-373 _28 September, 2000

PATENT ACT

Regulations Repealing the Manufacturing and Storage of Patented Medicines Regulations

P.C. 2000-1515 28 September, 2000

Her Excellency the Governor General in Council, on the rec­ ommendation of the Minister of Industry, pursuant to subsec­ tions 55.2(2)" and (3)" of the Patent Act, hereby makes the an­ nexed Regulations Repealing the Manufacturing and Storage of Patented Medicines Regulations.

REGULATIONS REPEALING THE MANUFACTURING AND STORAGE OF

PATENTED MEDICINES REGULATIONS

REPEAL

1. The Manufacturing and Storage of Patented Medicines Regulations1 are repealed.

.TRANSITIONAL PROVISION

2. For greater certainty, it is not an infringement of a pat­ ent for any person who makes, constructs, uses or sells a pat­ ented invention in accordance with subsection 55.2(1) of the Patent Act to make, construct or use the invention, during the six month period immediately preceding the date on which the term of the patent expires but before October 7, 2000, for the manufacture and storage of articles intended for sale after the date on which the term of the patent expires.

COMING INTO FORCE

~-~----:;:-rhese Regulations come llltofOrce on October 7, 2000.

REGULATORYDMPACT ANALYSIS STATEMENT

(This statement is notpart ofthe Regulations.)

Description

These Regulations repeal the Manufacturing and Storage of Patented Medicines Regulations.

The Manufacturing and Storage ofPatented Medicines Regu­ lations were enacted in 1993, as part of the reforms to the Patent Act brought into force with the passage of Bill C-91, An Act to Amend the Patent Act (1992). Foremost among these reformS wa$ · the phasing-out of the compulsory licencing regime, a federally regulated arrangement whereby second-entry drug manufacturers (usually generic drug companies) could, on the payment of royal­ ties to patent-holding innovator drug manufacturers (usually

• S.C. 1993, c. 2, s. 4 1 SOR/93-134

Enregistrement DORS/2000-373 28 septembre 2000

LOI SURLES BREVETS

Reglement abrogeant le Reglement sur Ia production et l'emmagasinage de medicaments brevetes

C.P. 2000-1515 28 septembre 2000

Sur recommanclation du ministre de l'Industrie et en vertu des paragraphes 55.2(2)" et (3)" de la Loi sur les brevets, Son Excel­ lence la Gouvemeure generale en conseil prend le Reglement abrogeant le Reglement sur Ia production et temmagasinage de medtcaments brevetes, ci-apres. .

REGLEMENTABROGEANTLE REGLEMENT SUR LA PRODUCTION ET

L'EMMAGASINAGE DE MEDICAMENTS BREVETES

ABROGATibN

1. Le Reglement sur Ia production et l'emmagasinage de me­ dicaments brevetes1 est abroge.

DISPOSITION TRANSITOIRE

2. II est entendu qu'il n'y a pas contrefa~on de brevet si !'utilisation, Ia fabrication, Ia construction ou Ia vente d'une invention brevetee, au sens du paragraphe 55.2(1) de Ia Loi sur les brevets, a lieu pendant la periode de six mois qui pre­ cede immediatement Ia date alaquelle expire le brevet, pour­ vu qu'elle ait lieu avant le 7 octobre 2000, et qu'elle a pour but la production et l'emmagasinage d'articles destines aetre vendus apres Ia date d'expiration du brevet.

ENTREE EN VIGUEUR

3. Le present reglement entre en vigueur le 7 octobre 2000.

RESUME DE L'ETUDE D'IMPACT DE LA REGLEMENTATION

(Ce resume nefait parpartie du reglement.)

Description

Le present reglement abroge le Reglement sur la production et l'emmagasinage de medicaments brevetes.

Le Reglement sur Ia production et l'emmagasinage de medi­ caments brevetes a ete promulgue en 1993, dans le cadre de la reforme de la Loi. sur les brevets entree en vigueur avec !'adoption du projet de loi 0'91, La·t-modifiant la Loi sur les bre­ vets (1992). La principale mesure de reforme etait !'elimination progressive du regime de licences obligatoires, un regime regie­ mente par Ie gouvemement federal en vertu duquelles deuxiemes fabricants (habituellement des compagnies generiques) pouvaient,

• L.C. 1993, ch. 2, art. 4 1 DORS/93-134